Improved assay for catechol-O-methyltransferase activity utilizing norepinephrine as an enzymatic substrate and reversed-phase high-performance liquid chromatography with fluorescence detection

被引:17
作者
Aoyama, N
Tsunoda, M
Imai, K
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan
[2] Musashino Univ, Res Inst Pharmaceut Sci, Tokyo 2028585, Japan
关键词
catechol-O-methyltransferase; norepinephrine as substrate; borate complex; HPLC-fluorescence detection; hypertension; Parkinson's disease;
D O I
10.1016/j.chroma.2005.03.037
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have previously established a rapid catechol-O-methyltransferase (COMT) assay using norepinephrine (NE) as a natural substrate and flow-injection analysis. In this study, the method is improved for screening of COMT inhibitors or activators using reversed-phase high-performance liquid chromatographic separation with fluorescence detection. The excess substrate, NE, was removed by the addition of borate in the eluent for HPLC to make an ionic complex with NE, which was eluted faster than the enzymatic product, normetanephrine. The method had good precision and accuracy, and was able to assay one sample in 5 min, showing the usability for screening of COMT inhibitors or activators. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 25 条
[1]   A rapid assay method for catechol-O-methyltransferase activity by flow injection analysis [J].
Aoyama, N ;
Tsunoda, M ;
Nakagomi, K ;
Imai, K .
BIOMEDICAL CHROMATOGRAPHY, 2002, 16 (04) :255-260
[2]   New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease [J].
Bonifati, V ;
Meco, G .
PHARMACOLOGY & THERAPEUTICS, 1999, 81 (01) :1-36
[3]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[4]  
DYCK SV, 2002, ELECTROPHORESIS, V23, P1341
[5]   FLUORIMETRIC ASSAY OF DOPAMINE, NOREPINEPHRINE AND THEIR 3-O-METHYL METABOLITES BY USING FLUORESCAMINE [J].
IMAI, K .
JOURNAL OF CHROMATOGRAPHY, 1975, 105 (01) :135-140
[6]   Attenuation of methylation of catecholamines and treatment with a coenzyme of catechol-O-methyltransferase in spontaneously hypertensive rats (SHR) [J].
Imai, K ;
Tsunoda, M ;
Takezawa, K ;
Mitsuhashi, K ;
Santa, T ;
Nagashima, K ;
Katayama, K ;
Ohmori, K .
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1999, 75 (07) :224-227
[7]   Catechol-O-methyltransferase and blood pressure in humans [J].
Jordan, J ;
Lipp, A ;
Tank, J ;
Schröder, C ;
Stoffels, M ;
Franke, G ;
Diedrich, A ;
Arnold, G ;
Goldstein, DS ;
Sharma, AM ;
Luft, FC .
CIRCULATION, 2002, 106 (04) :460-465
[8]   ANALYSIS OF PLASMA-CATECHOLAMINES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION - SIMPLE SAMPLE PREPARATION FOR PRECOLUMN FLUORESCENCE DERIVATIZATION [J].
KAMAHORI, M ;
TAKI, M ;
WATANABE, Y ;
MIURA, J .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 567 (02) :351-358
[9]   Radiochemical high-performance liquid chromatographic assay for the determination of catechol O-methyltransferase activity towards various substrates [J].
Lautala, P ;
Ulmanen, I ;
Taskinen, J .
JOURNAL OF CHROMATOGRAPHY B, 1999, 736 (1-2) :143-151
[10]  
Männistö PT, 1999, PHARMACOL REV, V51, P593